Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 36 Stomach Neoplasms 9 Colonic Neoplasms 6 Rectal Neoplasms 3 Sarcoma 2 Carcinoma, Hepatocellular 2 Advanced Colorectal Carcinoma 2 Unresectable Metastatic Colorectal Cancer 1 Platinum Resistant Ovarian Cancer 1 Patients With Advanced Metastatic Colorectal Cancer 1 Pancreatic Neoplasms 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 NSCLC 1 Metastatic Colorectal Adenocarcinoma 1 Metastasis Colorectal Cancer 1 Lung Neoplasms 1 Locally Advanced Rectal Cancer 1 Gastric/Gastroesophageal Junction Adenocarcinoma 1 Gastric Cancer Adenocarcinoma Metastatic 1 Fruquintinib 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Cancer Metastatic 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Adenocarcinoma 1 Advanced Solid Tumors 1 Advanced Pancreatic Carcinoma 1 Advanced Gastric Cancer 1

Interventions

Cisplatin 88 Fluorouracil 71 Paclitaxel 69 Radiotherapy 63 Oxaliplatin 55 Irinotecan 37 Docetaxel 36 Carboplatin 36 Leucovorin 34 Capecitabine 28 Radiation 25 Surgical Procedures, Operative 22 Drug Therapy 19 pembrolizumab 18 Cetuximab 15 Bevacizumab 15 Nivolumab 14 tislelizumab 12 camrelizumab 11 Neoadjuvant Therapy 11 Esophagectomy 11 Chemoradiotherapy 11 S 1 (combination) 10 Albumin-Bound Paclitaxel 10 nimotuzumab 9 Trastuzumab 9 durvalumab 8 Radiotherapy, Intensity-Modulated 8 Gefitinib 7 Epirubicin 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Esophageal Neoplasms × HMPL-013 × Clear all

NCT06646588 2024-10-17

SJZ-RMEEC01

Hebei Medical University Fourth Hospital

Phase 2 Recruiting

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡